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A qualitative study of cancer survivors’ responses to information on the long 
term and late effects of pelvic radiotherapy one to eleven years post treatment 
 
 
 
Abstract  
 
As more patients survive cancer for longer, the long term and late effects of treatments 
become increasingly important issues for cancer survivors and providing information to 
enable survivors to recognise and manage them becomes increasingly pressing 
challenges for health care professionals.  The aim of this study was to explore the 
experiences of cancer survivors regarding information given on potential long term and 
late effects of pelvic radiotherapy.  Semi-structured interviews were conducted with 28 
cancer survivors who had had radiotherapy to the pelvic area for a range of cancers 1 to 
11 years previously. Participants were recruited using maximum variation sampling from 
a larger questionnaire survey of patients treated at one hospital.  Interviews were 
recorded, transcribed and analysed using Framework.  Participants recognised the value 
of information to reassure and to inform action but also its potentially undesirable effects 
to frighten or raise anxieties about future problems and its inherent limitations in meeting 
their wider needs.  They identified the timing, amount of information and context in which 
it was given as of particular importance. Information based on personal experience was 
also valued.  These findings highlight the importance of appropriate, individualised 
information during treatment, at hospital discharge and subsequently in primary care. 
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Introduction 
 
Providing information to cancer patients is now widely recognised as an important aspect 
of care.  It has been shown to relieve anxiety and improve psychological wellbeing (Booth 
et al, 2005), enable patients to make informed treatment decisions (Ziegler et al, 2004), 
contribute to positive adjustment in the transition from active treatment (Stanton 2012; 
Sandsund et al, 2012) and empower patients to take an active role in their own health 
care (Rees et al, 2003).  The provision of information has been highlighted as a key 
priority in major policy documents internationally, including the Cancer Reform Strategy 
in England (Department of Health, 2007) and the report of the President’s Cancer Panel 
in the USA (President’s Cancer Panel, 2006). In the context of an increasing emphasis 
on patient choice (Department of Health 2004, 2010a, 2010b, 2010c), and supported 
self-management (National Cancer Survivorship Initiative, 2009; BC Ministry of Health, 
2011; http://selfmanagementuk.org/), concern with aspects of the provision of information 
to cancer patients is likely to continue to grow.   
 
Of the substantial body of research that has accumulated on this topic, most has focused 
on the information needs and information-seeking behaviour of patients at the time of 
diagnosis or active treatment.  Relatively little attention has been given to the information 
needs of cancer survivors in the years following the end of active treatment (Cappiello et 
al, 2007; Beckjord et al, 2008, Stanton, 2012).  For example, in a systematic review of 
cancer patients’ needs for and sources of information, Rutten et al (2005), observed that 
while cancer survivors in the post-treatment phase were well represented in the studies 
they reviewed, the majority had been asked to report on their information needs 
retrospectively with the result that ‘this body of literature primarily addresses patients’ 
information needs and sources during diagnosis and treatment’ (page 255).  Gansler et al 
(2010) also observed that while the information needs and priorities of people undergoing 
cancer treatment were extensively categorised, ‘less is known about information needs 
and priorities after completion of treatment and at the time of recurrence’ (page 310).   
 
Research conducted in recent years has begun to address this deficit and has suggested 
that the information needs of patients in the post-treatment survivorship years are quite 
distinctive.  While Rutten et al’s (2005) review reported that those in the post-diagnosis 
and active treatment stage were primarily concerned with cancer-specific information and 
treatment options and side-effects, studies of cancer patients in the post-treatment 
survivorship stage suggest that persisting adverse effects of treatment is a major area of 
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concern (Rozmovits et al, 2004; Cappiello et al 2007; Gansler et al, 2010; Stanton, 
2012).  Few studies, however, have considered when and how to provide cancer 
survivors with the information they may need to address this concern.  Without a better 
understanding of these issues, attempts to provide information may be of little value to 
patients.  
 
Radiotherapy is one of the most widely used forms of treatment offered to cancer 
patients and one for which there is growing evidence of long term adverse effects.  The 
aim of radiotherapy is to kill the target tumour cells whilst sparing nearby healthy tissue 
as far as possible but some damage to healthy tissue is inevitable.  Patients with pelvic 
cancers are commonly offered radiotherapy, often in combination with surgery, 
chemotherapy and hormonal therapy regimens.  Around 17,000 people are treated with 
pelvic radiotherapy each year in the UK alone (West and Davidson, 2009). Severe 
adverse effects are rare, but research suggests that up to 50% of patients are left with 
long term chronic gastrointestinal side effects including diarrhoea and faecal urgency or 
incontinence (Andreyev, 2007: Olopade et al, 2005; Putta and Andreyev, 2005; Das et al, 
2010).  Similarly, studies of patients treated for gynaecological cancers indicate that 20% 
to 50% of patients are left with symptoms associated with bladder, bowel or genitalia 
(Vistad et al, 2008; Maher and Denton, 2008; White, 2008; Routledge et al, 2003; Anacak 
et al, 2001).  These side effects can have a significant detrimental impact on the person’s 
physical and psychological wellbeing, and affect wide aspects of the person’s quality of 
life including their personal relationships (Barker et al, 2009; Cannon et al, 2009; 
Hedestig et al, 2005). However, most of this research is based on patients in the early 
survivorship stages and much less is known about the experience of longer term 
survivors who are no longer being followed-up by the hospital clinic.  
 
In order to investigate the long term and late effects of treatment and patients’ 
information needs in relation to them, we conducted a mixed methods study of cancer 
survivors who had had radiotherapy to the pelvic area for prostate, cervix, uterine, 
vaginal, rectal, and bladder cancer in the previous one to eleven years.  In a previous 
paper we reported the findings of a postal survey which described the prevalence of long 
term and late effects, the impact of time since treatment on the prevalence adverse 
effects and the relationship between adverse effects, psychological morbidity and quality 
of life (Adams et al, 2014).  As part of this study we also conducted an embedded 
qualitative study which explored a sub-group of respondents’ experiences of the long 
term and late effects of pelvic radiotherapy and their views on and responses to 
information provided in relation to these.  In this paper we focus on the information theme 
and describe the nature and range of participants’ responses to the information they were 
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given on long term and late effects of pelvic radiotherapy with a view to informing future 
clinical practice in this important area.   
 
 
Methods  
 
Recruitment 
All patients who received radiotherapy treatment with curative intent to the cervix, uterine, 
vagina, rectum, bladder or prostate, between 1999 and 2009 at one hospital in Oxford 
were eligible for inclusion in the initial questionnaire survey. The sample was stratified by 
gender and by time since treatment (1-5 years; 6-11 years). A random sample of men, 
and all women treated in this time period were selected to include approximately equal 
numbers of men and women.  Patients with a recurrence were excluded. Approval for the 
study was obtained from the Southampton & South West Hampshire Research Ethics 
Committee (Ref 10/H0502/60). A total of 849 participants (449 women and 400 men) 
were invited to participate. 
 
On the last page of the questionnaire, respondents were asked to indicate if they would 
be interested in participating in an interview study to follow up issues identified in the 
questionnaire.   
 
Of the 418 respondents who returned a completed questionnaire, 181 (43%) indicated 
that they would be interested in participating in an interview.  A maximum variation 
sample of 30 respondents was selected on the basis of gender, cancer site, time since 
treatment and responses to open-ended questions asking if there were any other issues 
they would like to raise, with a higher proportion of those who indicated they had 
something they wanted to say included in the sample.  
 
All participants who took part in the initial questionnaire survey were informed that they 
could order a copy of the Macmillan booklet ‘Pelvic Radiotherapy in Men/Women [as 
appropriate]: possible late effects’ and were given the free-phone number and website 
address.  The booklet included a general introduction to pelvic radiotherapy and its 
possible side effects, followed by sections on specific symptoms and how to deal with 
them, and a final section on other sources of help.  At the time of arranging the interview, 
participants in the interview study were asked if they had already received a copy of the 
booklet, and those who had not were sent a copy a few days prior to the interview.  The 
booklet thus provided a common basis for discussion of aspects of the provision of 
information on long term and late effects. 
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Data collection 
EA or MB contacted the selected respondents by telephone to provide further information 
on the interview study and, for those who were still interested in taking part, to arrange 
the time and place of the interviews.  Written consent was obtained before the interviews 
were conducted.   
 
Semi-structured interviews were conducted by EA or MB, both experienced qualitative 
interviewers, using a topic guide which had been constructed following a review of 
existing literature and consultation with user representatives and amended further 
following initial pilot interviews.  
 
The broad areas covered in the interview were:   
 
1.  Treatment received  
2.  Symptoms (adverse effects) experienced following treatment (immediate, on-going 
and late), their impact on everyday life, and how they managed them 
3.  What they were told about long term and late effects, by whom and when, and how 
they felt about this 
4.  What they had learned from other sources and how they felt about this 
5.  Views on the best time to provide information about long term and late effects and 
how it should be provided  
 
Interviews were conducted in the participants’ own home and lasted between 30 and 90 
minutes.  With participants’ consent, they were digitally audio-recorded and fully 
transcribed.   
 
 
Analysis of interviews 
 
Interviews were coded and analysed by MB (senior qualitative researcher in sociology of 
health and illness) using the Framework approach (Ritchie and Spencer, 1994; Lewis 
and Ritchie, 2003). Framework was developed specifically for applied and policy-relevant 
qualitative research where the objectives of the study are typically set in advance, often 
in relation to the needs of the funding body.  The analytical process involves five stages:  
familiarisation; identifying a thematic framework to index (code) the data; indexing; 
charting (summarising information under themes and sub-themes); and mapping and 
interpretation.  
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The first four interviews were also coded by EW (senior health service researcher) and 
discussed to agree and refine the thematic framework.  Throughout the analysis period 
MB and EW discussed how the thematic framework was applied to the data to ensure the 
credibility and trustworthiness of the analysis.  EA (health psychologist) reviewed the final 
analysis and report to the funder. 
 
In presenting the findings, quotes from the interviews are identified by the interview ID 
code (eg F56.022), followed by the age and gender of the participant, the cancer site and 
the number of years since treatment grouped into 1-5 years or 6-11 years.  An ellipsis (. . 
. ) is used to indicate the omission of words or sentences, and names of individuals or 
hospitals have been replaced with XXX.  Square brackets [  ] are used to indicate any 
additional information or précis of omitted words or sentences.   
 
 
Results 
Sample Characteristics 
Twenty eight interviews were completed (12 men and 16 women). Interviews with the 
other two patients could not be arranged in the time available.  The characteristics of 
study participants are given in Table 1.   
 
In terms of their experience of long term and late effects, interview participants described 
a similar range of bowel, urinary and sexual problems as those in the initial questionnaire 
sample.  For many these effects were significant and distressing but all had developed 
self-management strategies which enabled them to carry on their daily lives.  For some, 
however, this involved limiting their activities in ways which they regretted and which set 
them apart from their peers.   
 
Contrasting perceptions of information provided on immediate and long term or 
late effects of radiotherapy 
 
Most of those interviewed said that they had received excellent information and support 
from their clinical team regarding the immediate adverse effects of pelvic radiotherapy.   
 
F01.024 – 65, female, rectal, 6-11 
I definitely got information about the immediate side effects that I could have and 
felt pleased with myself that I wasn’t having them. I didn’t have any problems with 
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my skins and . . .  everybody gets tired when they’re having radiotherapy.  So I 
felt the information was [good], I found it quite good really. (333-342) 
 
M49.065 – 65, male, rectal, 1-5 
Yeah, they told me about both, the heating up thing is a radiotherapy thing.  You 
can feel tired, drowsy, that sort of thing, and they talked about the chemotherapy.  
There’s all sorts of different side effects, sickness, blisters in the mouth, general 
tiredness again and a nasty taste in your mouth all the time, a sort of metally 
taste.  (151-165) 
 
However, few participants appeared to be aware that these adverse effects could persist 
for a lengthy period or develop some time after the end of treatment. 
 
F56.020 – 67, female, uterine, 1-5 
All they told me was that you could have sickness and diarrhoea actually while 
you were having radiotherapy.  Nobody told me a thing about after. . . .  I just 
thought, that was it, but it wasn’t, there was still a lot to come but of course I had 
no idea of that. . (555-592) 
 
F89.063 – 67, female, rectal, 1-5 
As for late side effects of radiotherapy, I didn’t even know there was any. . . . Until 
I’d got that questionnaire I didn’t know that there was a possibility that I might get 
other things crop up and it be put down to that  (441-508) 
 
M93.010 – 76, male, rectal, 6-11 
I wasn’t really given much information at all about what possible reactions one 
would get.  I certainly didn’t think I’d get this shocking pain but I possibly might 
not have done. (854-861)  
 
 
Responses to information provided on long term and late effects 
In the course of the interviews, participants elaborated further on their assessments of 
the information they had received (from a variety of sources) on the long term and late 
effects of pelvic radiotherapy.  It is this aspect of the interviews that is the focus of this 
paper. 
 
Two main themes, each with three sub-themes, were identified in the interviews.  Figure 
1 shows the development of the final set of themes and sub-themes in the analysis 
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process. The first column shows the initial Thematic Framework developed and used in 
Indexing the transcripts.  The second column shows the revised thematic framework 
used in Charting the indexed transcripts.  The third column shows the final set of two 
broad themes – their response to what information they were given and to how it was 
given – with three sub-themes within each, which was developed by reviewing, 
comparing and contrasting the Charts in the final Mapping and Interpretation stage of 
Framework (Ritchie and Spencer, 1994; Lewis and Ritchie, 2003).   
 
 
1.  Responses to ‘what’ information was given 
In talking about what information they were given on the long term and late effects of 
pelvic radiotherapy, study participants described the complex and potentially 
contradictory ways in which they responded to it.  While the value of information was 
recognised, participants also expressed an awareness of its potentially undesirable 
effects and of its limitations in helping them deal with the consequences of cancer and its 
treatment. 
 
(i) Valued information for reassurance and to inform action 
The most common reason for valuing information was for the reassurance it provided.  
As the following examples suggest, by reducing uncertainty and relieving anxiety, 
information can lead to a marked improvement in patients’ quality of life. 
 
M49.135 – 80, male, prostate, 1-5 
I was so happy reading it [Macmillan booklet, first seen as a study participant].  
We came across, on every page we turned over it was relating something that 
was happening to me.  It was diarrhoea, it was wind, it was bleeding, it was 
tiredness – and you know it can happen immediately after or it can not be 
apparent until two or three months after or you could be stuck with it for life.  I 
thought ‘Well, I’m one of the unfortunate ones that’s stuck with it for life then, 
because it’s gone on and on.  But I felt relieved because I did think there was 
something the matter to be honest and every time I went to see the consultant I 
was expecting him to say something and he didn’t.    (1181-1190)  
 
F34.001 – 47, female, cervical, 6-11 
The thing I was concerned about was that I would have to stop taking Imodium or 
Loperamide. That was the one thing.  . . .  So I would have liked the information 
[in the Macmillan booklet, that I could continue to take Imodium indefinitely] 
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earlier because I was concerned and I was struggling because I felt I shouldn’t be 
taking it all the time [but it was the only thing that helped].  (1346 – 1359) 
 
Other participants valued information to inform action, enabling them, for example, to ask 
questions of their health care professionals, to make informed decisions and to take a 
more active role in their own health care.  Perhaps not surprisingly, this was particularly 
evident to those who felt that, at the time they had needed it, they had lacked information 
to take appropriate action, as the following examples illustrate: 
 
M93.059 – 67, male, bladder, 6-11 
If that [Macmillan booklet] had been around, that would have been helpful 
because from that you can then ask your own questions to your doctor.  (643-44) 
 
F45.006 – 55, female, cervical, 6-11 
I [would have liked] a much more detailed account of what happens when you are 
radiated.  If I’d known that it was going to deteriorate the bone, I would have 
known that I was looking at having a hip replacement several years sooner than I 
was planning to have one [and could have prepared for it].  (1028-1031) 
 
However, acknowledging the value of information did not necessarily mean that they 
wanted all the information that was available: 
 
F45.006 – 55, female, cervical, 6-11 
It is quite hard to know how to give that information without giving packs of 
leaflets and stuff that people don’t read, don’t want to read, because you don’t 
actually really want to know. 
 (499-502) 
 
 
(ii) Concerns about potentially undesired effects 
Participants recognised that information could also bring undesired consequences, 
observing that information could frighten people as well as reassure them, and in some 
cases potentially deter them from having treatment:    
 
M93.157 – 70, male, prostate, 6-11 
[The booklet] can give too much information at times of what could happen, as 
though they were trying to put you off from having the treatment.  . . .  I think it’s 
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too much, I don’t know if it will scare people off from having the treatment in the 
first place.  (493-524) 
 
 M49.121 –  51, male, bladder, 1-5 
 I’m being honest, I don’t think I would have had the radiotherapy if I’d have read 
that [Macmillan] book five years ago.  I don’t think I’d have had the radiotherapy 
because the pros and cons is too much against having it.  (527-538).  
 
Participants also pointed out that providing information on potential long term or late 
effects could create anxieties or negative expectations that they would experience those 
effects in the future and some expressed concern about the potential consequences of 
this:  
 
M49.094 – 80, male, bladder, 1-5 
I think it can be helpful but at the same time imagination can be a terrible thing.  I 
think if you suggest something, there’s every chance you’re sure you’ve got it, in 
your own mind.  (498-500) 
 
F56.022 – 63, female, uterine, 1-5 
. . . like all information you can almost build up an expectation about how people 
are going to feel and it isn’t necessarily so. (1615-1616) 
 
Others described the distressing impact that reading the Macmillan booklet had had on 
themselves: 
 
M49.121 – 51, male, bladder, 1-5 
It [Macmillan booklet] is quite shocking.  . . .  I thought ‘Am I experiencing just the 
start of it?’  That’s one of the things I asked myself when I had finished reading 
that book.  I thought, ‘Oh god, this might just be the start of a lot more problems 
to come on.’ (1305-1312) 
 
A further but less common concern was that, by identifying certain symptoms as long 
term or late effects of pelvic radiotherapy, cancer survivors might be misled as to their 
meaning and miss the early signs of cancer recurrence: 
 
F56.022 – 63, female, uterine, 1-5 
It says the long term side effects, and then it puts tiredness, and I’m thinking ‘Well 
surely that – what do you mean by long-term and tiredness?  How long should 
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you expect to feel tired?’   . . . What I mean is that you might not report that you’re 
still very tired when in fact it’s a symptom that you are not at all well.  . . .  That 
might be the immediate effect after radiotherapy but [3 years on] there’s 
something very wrong, you shouldn’t expect to feel tired.   (1576-1611) 
 
(iii)  Encountered its limitations in meeting their support needs 
Finally, some participants had encountered the limits of information in meeting their wider 
support needs.  Some described this in relation to the limitations of information alone in 
preparing them for the reality of the experience and in addressing its emotional impact: 
 
F45.006 – 55, female, cervical, 6-11 
 . . . I did read up on these things and I had an idea of what it was going to be like.  
But until you’re actually in that situation, you’ve no idea.  (199-201) 
 
F78.053 – 39, female, rectal, 1-5 
So yeah, there was information given but I just, I just felt it was very cold.  I don’t 
expect anybody to go ‘oh there, there love, it’s all going to be better’ but it was 
just . . .  you’re totally on your own all the time.  (489-494) 
 
Others described it in terms of the inability of factual information or practical advice to 
answer more existential concerns or change the reality of a cancer diagnosis.   
 
 F78.053 – 39, female, rectal, 1-5 
You do think to yourself, ‘why me’?  I was 35 years old with a young family.  OK, 
I’m still here, I should be grateful, there are people out there that’ve got terminal 
cancer, and da de da, but yeah, I do think to myself ‘why’, yeah I do.  (398-402) 
 
M49:135 – 81, male, prostate, 1-5 
I I don’t want to know.  I know what is wrong, I know the treatment I’m having.  I 
don’t want to know the ins and outs and all that.  I suppose it’s like putting your 
head in the sand, but I think you can discuss it and go over it, over and over 
again, and it doesn’t make it any better, does it.  (1357-1361) 
 
 
2. Response to ‘how’ information was given 
Participants’ accounts also highlighted the importance of how information was provided, 
including the timing, amount and context in which it was given.  Information based on 
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personal experience was valued in meeting a range of needs not addressed by medical 
science.    
 
(iv) Timing 
A common theme in the interviews was the importance of timing. Most participants had a 
view on what times were better or worse for receiving information on long term and late 
effects though not all agreed as to what they were.  Some participants wanted 
information on both immediate and long term and late effects as soon as the decision to 
give radiotherapy had been made and before treatment started:   
 
M49.121 – 51, male, bladder, 1-5 
Right at the beginning before you actually have it.  Definitely.  I think you should 
be made more aware of what could possibly happen. (493-507)  
 
M93.173 – 80, male, prostate, 6-11 
I think they should tell them all of this [early on], so that they can make their own 
mind up.  I think probably they should.  I mean, it they’d have told me all this, I 
would still have gone ahead with it because I wanted to live, you see. 
(615-621)  
 
As these quotes suggest, the rationale for giving information before the start of treatment 
was to give patients the opportunity to make an informed decision about whether to have 
radiotherapy or not.  However, participants also described being pre-occupied in the early 
post-diagnosis stage with more immediate and profound concerns regarding their own 
survival which meant they were not receptive to information on potential adverse effects 
of radiotherapy which might (or might not) occur in the distant and uncertain future:  
 
M49.073 – 56, male, rectal, 1-5 
When you’ve been told you’ve got cancer and you’re going to have radiotherapy, 
and even if they said these are the possible side effects, I don’t think we even 
took it on board. Because there isn’t a choice, is there, really.  If somebody said, 
‘If you do survive you’re going to have waterwork problems, sexual problems, etc, 
etc’ you wouldn’t go, ‘Oh well, I think I’ll die then,’ would you?  You have to put it 
in perspective.  (829 - 835) 
 
M93.134 – 76, male, rectal, 6-11 
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It doesn’t take many minutes to go through a few side effects that might occur. . . 
[But] then people don’t listen, really.  When they’re told they’ve got cancer, they 
don’t listen anymore.  It shuts their mind off.  (750-753) 
 
This may help explain why participants were not generally aware of potential long term or 
late effects of pelvic radiotherapy prior to the study.  Health care professionals may 
routinely raise the implications of treatment, including long term and late effects, as part 
of the process of informed consent but because they are so remote from their current 
concerns, patients may not be able to take it in.  It may also help explain the view that 
information on long term and late effects was best provided after radiotherapy had been 
completed, when they had had time to recover, or at the point of discharge from hospital 
follow-up, when they had begun begin to think about the future. 
 
M93.034 – 76, male, rectal, 6-11 
I would say, let people get over it because it’s quite a traumatic thing all the way 
through, it really is.  I would say three months, because they check you as regular 
as anything there.  I would have thought then.   (616-629);  
 
F12.012 – 75, female, uterine, 6-11 
I would say to give it to people when they’re better, when they’re in remission or 
whatever and surgery has been successful.  I don’t know, I suppose a year, 
about a year.  (453 – 457) 
 
F34.001 – 47, female, cervical, 6-11 
I think probably a year after my treatment I would have loved that [Macmillan] 
booklet.  I think anything before then would have been too soon.  . . .  It’s only 
after the event, you know [that you are ready to hear more].  I’ve been five years 
clear, or seven years clear, [and] its only after the event that you actually stop 
thinking about the cancer and start thinking about you.   (1316-39) 
 
Others suggested that no single time was best for providing information on long term and 
late effects but that information needed to be provided at ‘appropriate’ times throughout 
their lives as cancer survivors: 
 
 M93:010 – 76, male, rectal, 6-11  
I think once the trouble has happened, it’s too late.  On the other hand, you don’t 
want to scare them.  I think the easiest thing would be to say that you will find 
differences in your lifestyle, physically.  Don’t hang about, go to your GP or stoma 
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nurse or whatever, straight away and then they could take you up the ladder.  . . .  
So a certain amount wants to be before, but maybe not the whole bucketful.  But 
certainly a lot more than I had.  (870 - 880) 
 
M49.065 - 65, male, rectal, 1-5  
[I think give information] afterwards, because you’re going to get all these 
symptoms after, not before, so you can read all that and say, ‘Crumbs, I’m going 
to have all these symptoms’ and no, because you won’t have all them symptoms.  
I think afterwards but if people want to have it before, let them have it before, if it 
reassures them in some way or they want to know what they’re going to 
experience.  (852-857) 
 
It is also interesting to note that those given the Macmillan booklet as part of this study up 
to 11 years after treatment nonetheless reported benefits from reading it in terms of 
reassurance and the practical management of long term effects. 
 
 
(v) amount and context of written information 
Also important to patients was the way information was given, which could make it more 
or less accessible and acceptable.  For written information in particular, too much 
information or too much detail was seen as counter-productive:  large quantities of 
information were regarded as too indigestible for patients to finish reading or too 
intimidating for them even to start: 
  
M93.134 –79, male, prostate, 6-11 
You don’t want too much information.  It’s like the Maggie’s Centre produce a 
booklet but I would say that probably 50% of people do not read all of it.  . . . We 
all sat around the table and decided that an A4 size is the best thing, because it’s 
less reading.  It gives you the  information on an A4 sheet which is folded into a 
booklet. . . . We found that people like that, because they can read all of it and 
not sort of say ‘Oh, I can’t read any more of that.’  (426-437) 
 
Some participants added that extensive information was likely to be more worrying: 
 
 M49.094 – 80, male, bladder, 1-5 
 I mean the more they tell you the more you’ve got to worry about.  I suppose it 
depends how onerous the things they haven’t told you could have been.  (461-
463) 
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M93.157 –  71, male, prostate, 6-11 
Going through [Macmillan booklet], I think [it gives] too much information at times 
of what could happen, as though they were trying to put you off from having the 
treatment. . . . [It’s] too much, too much information.  (493-525)  
 
Amongst women in particular, the context in which written information was given was 
also important:  information was valued most when it was given in the context of an 
established, supportive personal relationship, for example with their specialist cancer 
nurse.  Several participants made the point that this personal relationship changed the 
nature of the exchange so that they took notice of information sheets or booklets they 
would otherwise have ignored, and felt supported and reassured by this exchange with 
their cancer nurse itself. 
  
F56.022 – 63, female, uterine, 1-5 
The fact that she gave me the book made a difference.  She didn’t say, ‘Phone 
up and you can get one.’  . . .   It was the fact that she gave it to me and said ‘if 
you need any more information, come back to me  . . .   I think the best way is 
person-to-person.    (740-787) 
 
F34.001 – 47, female, cervical, 6-11 
I think if [just any] nurse had given me that booklet I would have treated it exactly 
the same as the letters coming through the post – you read it, you scan through it 
and you put it away.  But having that relationship with [the Clinical Nurse 
Specialist], . . .  if she said ‘This is going to help’, I trusted her.  We already had 
that relationship, so it wasn’t a stranger giving it to me.  . . .   Knowing that you’ve 
got information and a safety net is the key.   (1475 – 15280) 
 
 
 (vi) The unique value of experience-based information 
While participants valued the information given by clinical staff and other ‘medical’ 
sources, they also valued the information provided by other patients who brought a 
different kind of expertise based on personal experience.  Clinic staff encouraged this, 
recognising that patients were better placed to provide both hope and reassurance about 
the future and the kind of practical information and advice that they would find helpful in 
managing everyday life.  Participants themselves described how they had taken strength 
from the experience of other patients: 
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 M93.157 – 70, male, prostate, 6-11 
A colleague, her cousin had the same as what I eventually had and she told me 
how well it had gone and he’d completed cleared now and everything, which 
helped no end.  (606 - 612) 
 
F01.024 – 65, female, rectal, 6-11 
I can remember being in some support groups and things where I had a chat with 
the odd person, which really helped me in my decision about having a swap from 
an ileostomy to a colostomy.  I got a lot of useful information in making that 
decision, so I think access to that sort of [. . . thing] is very good.  (801-810) 
 
They also described how they looked to more experienced patients for practical advice in 
managing the long term treatment effects, and found it particularly helpful. 
 
F56.051 – 84, female, uterine, 1-5 
I go to meetings [of a stoma group] four times a year in [town], you know.  I go to 
see if I can find out anything.  You always wonder, you like to talk to somebody 
who’s got one [ileostomy] the same so you can compare notes.  (420-422) 
 
F34.001 – 47, female, cervical, 6-11 
I think it would be really good if there was a body of people that were on a phone 
list, of varying ages, that had experienced it, that people could ring and say ‘Can I 
just ask you something?’.  . . .   Because there have been occasions I wish I 
could just ask someone who isn’t a professional. (1907-1916) 
 
Finally, participants described how the exchange of views and experience with other 
cancer survivors helped them meet the emotional and existential needs that ‘medical’ 
information alone could not meet.  Support groups for cancer patients and survivors 
provided a supportive community and a reference group through which they could make 
sense of what was happening to them and make the psycho-social adjustments needed 
as a cancer survivor.    
  
 M93.134 – 78, male, prostate, 6-11` 
 I went to [a group for prostate cancer at the XXX hospital] and I spoke to various 
people about different things and I think that is the way you can get over a lot of 
these problems, by people talking together about their problems. (214-217) 
 
 F12:038 – 83, female, rectal, 6-11 
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 Once I knew I had cancer I wanted to meet somebody else that had cancer and 
the same cancer that I had.  . . .  It’s one of the few cancers that people are a bit 
shy about and really when you go into hospital and you find everybody in the 
beds opposite, by the side, has the same thing, you don’t feel you’re on your own 
any more.  (446-545) 
 
As they suggest, other patients with whom they could share their experiences and 
concerns, speak about taboo subjects and feel ‘normal’ provided the support they 
needed to learn how to manage their condition and the effects of treatment and to 
construct a new identity as a cancer survivor. 
 
 
Discussion 
 
Summary of findings 
As more patients survive cancer for longer, the long term and late effects of treatments 
are becoming an increasingly important issue for cancer survivors and providing 
information to enable cancer survivors (and their partners) to recognise and manage 
them is becoming an increasingly pressing challenge for health care services (Hedestig 
et al, 2005; Andreyev, 2007; Maher and Denton, 2008; White 2008; Hazewinkel et al, 
2009).  While previous studies have begun to document cancer survivors’ desire for 
information on long term effects of treatment (Gray et al, 1998; Thewes et al, 2004; 
Gansler et al, 2010), this study is amongst the first to explore in detail survivors’ 
responses to information on this topic and their views on how it might be best provided.  
In common with other studies (Jenkins et al, 2001; Cox et al, 2006), we found that 
survivors valued information on long term and late effects of treatment.  However, we 
also found that they appraised information, and how it was provided, in more critical 
terms than might have been expected.  While there were positive comments on 
information provided on immediate adverse effects of radiotherapy, many participants 
were not aware that adverse effects could continue or emerge after the end of treatment.  
Their views on and responses to the provision of information underline the complexities 
and challenges faced by health care professionals in helping patient and carers prepare 
for potential adverse effects of radiotherapy to the pelvic area.  Participants observed that 
information was not always welcome, describing a range of potentially undesirable 
effects and the limitations of information alone in meeting their needs.  They also 
identified a number of considerations associated with the timing of information and the 
way and context it was given as well as the unique value of other patients’ experience.  
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Overall, what participants wanted was ‘just enough’ information, delivered in a personal 
context, at the times it was relevant to them.   
 
The range and variety of responses to what and how information was provided raise 
many challenges for those who wish to support cancer patients and their carers.  These 
are compounded by the limitations of medical knowledge itself: there is currently no 
reliable model to predict who will go on to develop long term treatment effects nor any 
predictive marker to inform what information should be given to patients.  While printed 
booklets and up-to-date websites may be of great value in providing information on long 
term and late effects of pelvic radiotherapy, our findings suggest that health care 
professionals need to discuss with patients themselves what information they want and 
how they want to receive it and to do so iteratively over the course of the treatment, 
follow-up and survivorship stages (Russell and Ward, 2011; Zeugler et al. 2012).  
 
Relationship to previous literature  
While a number of surveys have reported that most cancer patients want as much 
information as possible on their condition and its treatment (eg Jenkins et al 2001, 
Wittmann et al, 2011) and that a significant minority are dissatisfied with the amount they 
receive (eg Jones et al, 1999), qualitative studies have begun to challenge the simplistic 
nature of these findings.  Our finding that cancer survivors did not always welcome 
information is consistent with previous studies conducted at earlier stages in the cancer 
journey (Czaja et al, 2003; Friis, 2003).  Leydon et al (2000), for example, in a study of 
patients with a variety of cancer types, reported that their participants found even basic 
information frightening and argued that this was one of the main reasons for patients not 
seeking, or actively resisting, information.  Our study suggests that this may remain the 
case at much later stages in the cancer journey and that in addition to frightening cancer 
survivors, information is seen as potentially leading to other undesirable effects, such as 
anxieties or negative expectations about future adverse treatment effects and obscuring 
the symptoms of a possible recurrence of cancer. 
 
In addition, our study has reported novel findings on survivors’ perceptions of the 
limitations of information in meeting their supportive care needs.  Study participants 
described the ways in which they felt ‘let down’ or ‘disappointed’ by information on its 
own.  While information may have enabled them to know about long term treatment 
effects, it could not adequately prepare them for the experience of those effects or their 
impact on their life.  Similarly, information could inform them of what was likely to happen 
but it could not answer the more spiritual or existential questions of why it had happened 
to them and while it could inform action, it could not change the basic facts of their 
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situation.  Information was important but they conveyed their shock and frustration when 
they encountered its limitations in meeting their needs. 
 
Our findings have also pointed to the importance of timing in providing information, 
particularly in relation to the emotional readiness of cancer survivors and the relevance of 
the information to daily life.  While there were advocates for giving information at a variety 
of points, many participants expressed the view that the post-treatment stage was a 
particularly good time.  This is consistent with the findings of other studies (Sandsund et 
al, 2012).  Friis et al (2003), for example, reported that patients did not recall detailed 
information given in the post-diagnosis stage which they explained in terms of a ‘shock 
reaction’ to the diagnosis, while Gansler et al (2010) found patients were little interested 
in long term side effects until after treatment was completed, when the effects were 
expected to occur.  This evidence suggests that, while the diagnosis and active treatment 
stage may provide a ‘teachable moment’ for motivating individuals to adapt risk-reducing 
behaviours (McBride et al, 2003; Rabin, 2009), this is unlikely to be the case in relation to 
managing late and long term effects of treatment.   
 
An interesting finding of our study was that for several female participants it was 
particularly important that information booklets were given to them by a health care 
professional with whom they had an established a personal relationship.  This may reflect 
a shift in the nature of trust, characteristic of late modern society (Giddens 1990), which 
has been observed in other health care contexts (Alasewski & Horlkick-Jones, 2003; 
Brown 2009).  While trust in the source of information is fundamental to its effectiveness, 
it can no longer be assumed that patients have trust in health care professionals and the 
publications they produce simply on the basis of their professional status or institutional 
accreditation.  Trust must now by earned through the quality of the relationship a 
professional establishes with an individual patient and the competence, care and 
empathy that she or he displays (Taylor Gooby and Zinn 2006; Calnan and Rowe 2008).  
Information provided in the context of such a relationship may also carry a weight of 
meaning and significance beyond that of the substance of the information itself, and may 
go some way to meeting the emotional support needs not met by information on its own.  
Our finding that participants also looked to other patients for information of a different 
kind is also consistent with a growing challenge to professional authority and a widening 
of the basis for claims to expertise in late modernity and is also supported by the findings 
of other studies.     
 
Implications for clinical practice 
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While previous studies have documented that information needs change over time (eg 
Matsuyama et al, 2013) and may decrease post-treatment (eg Guleser et al 2001; van 
Weert et a, 2013), we are not aware of any other study that has examined patients’ 
information needs and preferences up to 11 years period post-treatment.  The findings of 
this and other studies (Gamble, 1998; Guleser et al, 2001; Zeugers et al, 2012) suggest 
that patients want information on the side effects of radiotherapy but may not see 
information on long term and late effects as relevant, nor be able to take it in, during the 
active treatment stage.  Providing information on the adverse effects of radiotherapy 
throughout active treatment, follow-up and survivorship, and addressing questions that 
patients themselves define as relevant at the time they arise, may prove more effective.  
Patients may find particular benefit when such information is provided in the first 
outpatient appointment following the end of treatment. An information booklet such as the 
one used in this study (Macmillan Cancer Support, 2009), for example, can be valuable 
at this stage in helping patients manage long term effects (Andreyev et al, 2013).  Any 
continuing concerns or questions could be elicited and addressed in subsequent 
appointments and reviewed at the final appointment before discharge from hospital follow 
up.   
 
As written information on long-term and late effects may cause anxiety or distress or the 
need for further clarification, it may be best provided by a health care professional with 
whom the patient has an established relationship.  In the early years following treatment 
this is likely to be a member of the hospital team such as a clinical nurse specialist or 
radiographer.  However, with the likely increase in supported early discharge of cancer 
patients from hospital care in the England (National Cancer Survivorship Initiative, 2009) 
GPs may be required to play a greater role in the future.  This might involve, for example, 
a treatment summary provided to both GP and patient at discharge from hospital care.   
Such a document could help empower patients to request further review of possible long 
term effects and also act as a reminder to the GP to ask routinely if the patient has any 
questions or concerns.  GPs themselves are likely to need some preparation to deal with 
this and more work is needed to establish what this is likely to entail and how it could be 
provided (Watson et al, 2010).   
 
Health professionals are also in a good position to support patients in meeting other 
patients with similar conditions and should be encouraged to do so through individual 
patient contacts, local support groups such as a Maggie’s Centre or more formal services 
such as the expert patient programme (Wilson, 2008). 
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Strengths, limitations and reflections on the study 
Strengths of this study are the inclusion of both men and women, the variety of pelvic 
cancer types and the range in time since treatment, up to 11 years.  Limitations include 
the restriction of recruitment to one centre and the low number of participants from ethnic 
minority backgrounds.  As patients who had experienced a recurrence of cancer were 
excluded, the sample may have been healthier than the population from which it was 
drawn and less likely to experience, or more able to deal with, long term effects.  In 
addition, while the response rate to the main survey was relatively good (56%), it is 
possible that those who completed the questionnaire were not representative of the 
sample as a whole.  This may have been compounded by the sampling procedure for the 
interview study which selected more of those who indicated they had something they 
wanted to talk about.   
 
As with all qualitative research, this study was shaped by the context in which the 
interviews were carried out.  We used an information booklet produced by Macmillan 
Cancer Support, a well known and respected charity which also funded the study, as an 
example of information that could be provided to individuals who had had radiotherapy to 
the pelvic area.  Had we used a different booklet or not used one at all, we might have 
elicited a different set of comments.  However, using an existing booklet helped 
participants to focus attention on specific aspects of information provision and provided 
common ground for comments across the interviews.  While most participants made 
positive comments about the booklet, many also made critical comments.  More 
importantly, they did not restrict their comments to the Macmillan booklet but ranged 
widely in discussing information they had obtained from other sources, including health 
care professionals and other patients.   
 
The analysis of qualitative data is also shaped by the views, assumptions and interests of 
the research team as well as the circumstances and characteristics of the participants.  
The research team was guided by a strong sense of advocacy and a desire to improve 
supportive care and information for cancer survivors, a stance which appeared to be 
shared by the participants who largely wanted to contribute their views and experience 
for the benefit of others.  This common desire to ‘improve’ provision of information may 
have encouraged a particularly critical approach in the interviews and a focus on the 
problems of information provision in the analysis of the interviews.  However, the range of 
views expressed suggests a degree of balance was achieved overall.  
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Table 1:  Characteristics of sample  
 
 
 Females (n = 16) 
n  (%) 
Males (n = 12) 
N  (%) 
Total (n = 28) 
N (%) 
Age:       < 40 1 (  6) 0   1 (  4) 
                  40 – 49 4 (25) 0   4 (14) 
                  50 – 59 1 (  6) 2 (17)   3 (11) 
                  60 – 69 6 (38) 2 (17)   8 (29) 
                  70 – 79 1 (  6) 5 (42)   6 (21) 
                  80 + 3 (19) 3 (25)   6 (21) 
Mean age:  61.5 years 72.6 years  
    
Diagnosis:    
                  Bladder 1 (  7) 3 (27)   4 (14) 
                  Rectal 6 (38) 4 (36) 10 (36) 
                  Cervical 4 (25)    4 (14) 
                  Endometrium/ 
                  uterus 
5 (31)    5 (18) 
                  Prostate  5 (36)   5 (18) 
    
Treatment (in addition to 
radiotherapy) 
   
                 Surgery 6 (38) 2 (17) 8 (29) 
                 Chemotherapy 4 (25) 1 (  8) 5 (18) 
                 Hormones 0 1 (  8) 1 (  4) 
                 Surgery &               
      Chemotherapy 
4 (25) 4 (33) 8 (29) 
      Surgery,     
      Chemotherapy & 
      Hormones 
2 (13)  2 (  7) 
      Other, none     4 (33) 4 (14) 
    
Time since Treatment:    
                 1 to 5 years 8 (50) 6 (50) 14 (50) 
                 6 to 11 years 8 (50) 6 (50) 14 (50) 
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Figure 1:  Development of themes over the course of analysis 
 
Initial framework based 
on a priori issues 
Revised Framework used in 
indexing 
Themes used to map range of views & 
experiences, grouped under two broad 
headings 
 Impact of information itself 1. Response to what information was 
given 
What information provided 
(topics raised): 
• Bladder 
• Bowel 
• Fatigue 
• Sexual function 
• Other male 
• Other female 
Benefits of information 
• Reassurance (reduce 
uncertainty) 
• Act more effectively 
• Informed decisions 
• Ask questions 
• Explain to others 
• Plan for future 
Valued information:  
• For reassurance (reducing uncertainty 
relieves anxiety) 
• To inform action: 
• Ask questions and explain to 
others 
• Make informed decisions 
• Take active role in managing 
treatment effects 
 Costs of information 
• Frighten (create anxiety) 
• Create expectations of 
future effects 
• Obscure early signs of 
recurrence 
Concerned about potential undesired 
consequences 
• Frighten  
• Create anxieties or negative 
expectations for future  
• Obscure/miss early signs of recurrence 
 Limitations of ‘factual’ 
information alone 
• Does not prepare for the 
experience 
• How it is provided also 
important  
• Too general, not specific 
to individual  
• Does not change things 
Encountered its limitations in meeting their 
support needs. 
• Cannot prepare them for ‘reality’ of 
experience or its emotional impact 
• Cannot answer existential questions 
• Cannot change the basic facts 
   
 Aspects of providing 
information 
2. Response to how information was 
given 
When was information 
provided: 
• When provided 
• Best time to provide 
Preferred timing of information 
• Before radiotherapy 
• At end of radiotherapy 
• After discharge from 
follow-up 
Timing of information  
• Early in order to make informed choice 
• Not early on while preoccupied with 
diagnosis and treatment and so 
unreceptive 
• After end of treatment when ready to 
think of future  
• Whenever information is relevant to 
current concerns 
Sources of information: 
• Clinic staff (doctors, 
nurses) 
• Printed information 
• Internet 
• Other patients 
• Support groups 
Sources of information: 
• Clinic staff (doctors, 
nurses) 
• Printed information 
• Internet 
• Other patients 
• Support groups 
The amount and context of written 
information  
• too much information is counter-
productive 
• best provided in context of personal 
relationship 
 
Satisfaction with 
information 
• Satisfied (met needs) 
• Would like more (not 
met needs) 
• Suggestions for 
improving 
Amount & level of detail of 
information 
• About right 
• Would like more 
• Too much 
• Not relevant 
Unique value of experience-based 
information from other patients 
• Inspires hope and reassurance 
• Provides practical advice 
• Facilitates psycho-social adjustments 
 
